Rubidium API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Rubidium API 7440-17-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Rubidium. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Rubidium
- Synonyms:
- rubidio
- Cas Number:
- 7440-17-7
- DrugBank number:
- DB11346
- Unique Ingredient Identifier:
- MLT4718TJW
General Description:
Rubidium is a chemical compound identified by the CAS number 7440-17-7. It is known for its distinct pharmacological properties and applications.
Classification:
Rubidium belongs to the class of inorganic compounds known as homogeneous alkali metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a alkali metal atom, classified under the direct parent group Homogeneous alkali metal compounds. This compound is a part of the Inorganic compounds, falling under the Homogeneous metal compounds superclass, and categorized within the Homogeneous alkali metal compounds class, specifically within the None subclass.
Categories:
Rubidium is categorized under the following therapeutic classes: Elements, Metals, Metals, Alkali, Metals, Heavy. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Rubidium is a type of Alkalinizing agents
Alkalinizing agents, a pharmaceutical API category, refers to a group of substances used to increase the pH (alkalinity) of a solution or body fluid. These agents play a crucial role in various medical applications, such as the treatment of acidosis, kidney disorders, and certain drug overdoses.
One commonly used alkalinizing agent is sodium bicarbonate, which is highly effective in raising the pH of blood and urine. It works by neutralizing excess acid and restoring the acid-base balance in the body. Sodium bicarbonate is often administered intravenously in emergency situations to rapidly correct severe acidosis.
Another alkalinizing agent, acetazolamide, is frequently employed in the treatment of glaucoma and certain types of epilepsy. By inhibiting carbonic anhydrase, acetazolamide reduces the production of bicarbonate ions, leading to a systemic decrease in pH. This mechanism is particularly useful in lowering the intraocular pressure associated with glaucoma.
Alkalinizing agents are also utilized in the management of certain drug toxicities. For instance, methotrexate, a chemotherapy medication, can cause severe toxicity if its elimination is hindered. Alkalinizing the urine with agents like sodium bicarbonate enhances methotrexate solubility, preventing the formation of toxic crystals in the kidneys.
In conclusion, alkalinizing agents are indispensable pharmaceutical APIs that help correct acid-base imbalances, treat specific medical conditions, and mitigate drug toxicities. Their diverse applications make them valuable tools in modern medicine.
